Preoperative Single-dose Steroid Application for the Treatment of Nausea and Vomiting After Thyroid Surgery

NCT ID: NCT01189292

Last Updated: 2015-07-07

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

152 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-01-31

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is to compare the postoperative recovery, as determined by postoperative nausea and vomiting (PONV) after preoperative application of single-dose dexamethasone versus saline in patients undergoing partial or total thyroidectomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thyroidectomy Thyroid Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dexamethasone injection

Administration of 8mg(2ml) intravenous Dexamethasone (Mephameson®)

Group Type ACTIVE_COMPARATOR

Dexamethasone

Intervention Type DRUG

8mg (2ml) of dexamethasone (Mephameson®) administered intravenously preoperatively before thyroid surgery

Placebo (NaCl 0.9%)

Group Type PLACEBO_COMPARATOR

NaCl 0.9%

Intervention Type OTHER

2ml of NaCl 0.9% administered intravenously preoperatively before thyroid surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dexamethasone

8mg (2ml) of dexamethasone (Mephameson®) administered intravenously preoperatively before thyroid surgery

Intervention Type DRUG

NaCl 0.9%

2ml of NaCl 0.9% administered intravenously preoperatively before thyroid surgery

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Mephameson

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 18
* Planned partial or total thyroidectomy

Exclusion Criteria

* History of adverse effects to dexamethasone or propyleneglycol or di-natrium-EDTA
* Patients with chronic pain
* Necessity for opioids-application in the postoperative course
* Not possible administration of a cervical block (0.5% bupivacaine at a dose of 20ml)
* Patients with Diabetes mellitus
* Pregnancy (test in young women)
* Glaucoma
* Patients who received antiemetic therapy within 48h before surgery
* Patients with acute pain requiring painkillers others than paracetamol or more than single dose NSAR treatment within 48h before surgery
* Use of psychotropic drugs
* Incompliant patients
* Preoperatively high suspicion of malignancy
* Re-operations
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cantonal Hospital of St. Gallen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ignazio Tarantino

M.D:

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Clerici, MD

Role: PRINCIPAL_INVESTIGATOR

Cantonal Hospital St. Gallen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Surgery

Sankt Gallen, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Tarantino I, Warschkow R, Beutner U, Kolb W, Luthi A, Luthi C, Schmied BM, Clerici T. Efficacy of a Single Preoperative Dexamethasone Dose to Prevent Nausea and Vomiting After Thyroidectomy (the tPONV Study): A Randomized, Double-blind, Placebo-controlled Clinical Trial. Ann Surg. 2015 Dec;262(6):934-40. doi: 10.1097/SLA.0000000000001112.

Reference Type DERIVED
PMID: 25563879 (View on PubMed)

Tarantino I, Beutner U, Kolb W, Muller SA, Luthi C, Luthi A, Schmied BM, Clerici T, Warschkow R. Study protocol for a randomized, double-blind, placebo-controlled trial of a single preoperative steroid dose to prevent nausea and vomiting after thyroidectomy: the tPONV study. BMC Anesthesiol. 2013 Sep 9;13(1):19. doi: 10.1186/1471-2253-13-19.

Reference Type DERIVED
PMID: 24015953 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EKSG 10/082/2B

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Novel Approaches to the Treatment of Hypothyroidism
NCT06731764 RECRUITING PHASE2/PHASE3